Journal of Oncology & Targeted Therapies

About the Journal

Journal of Oncology & Targeted Therapies: Open Access is a peer-reviewed, Open Access scientific journal dedicated to publishing the most complete and reliable source of information on the applications, discoveries, and current developments in the field of oncology and targeted cancer therapies. The journal accepts and publishes original research articles, review articles, case reports, short communications, and other scientific contributions that cover all dimensions of cancer science and precision treatment approaches. All published content is freely accessible online, without restrictions or subscription barriers, allowing worldwide dissemination of knowledge to the global research and medical community.

Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. With the rise of targeted therapies, modern cancer care has moved beyond traditional chemotherapy to focus on molecular-level interventions that target specific genes, proteins, and the tissue environment contributing to cancer growth. These therapies offer personalized treatment strategies, reduce side effects, and improve outcomes in many types of cancer.

Targeted therapy involves drugs or other substances that block the growth and spread of cancer by interfering with specific molecules involved in tumor development. These treatments are often combined with other cancer therapies and are at the forefront of precision medicine.

The Journal of Oncology & Targeted Therapies explores a wide range of cancer-related topics, including but not limited to:

• Molecular oncology
• Tumor biology and microenvironment
• Signal transduction pathways
• Immunotherapy and cancer vaccines
• Biomarkers for diagnosis and prognosis
• Pharmacogenomics and drug resistance
• Combination therapies and clinical trials
• Cancer prevention and early detection
• Personalized and precision oncology

The journal covers research across 32 major types of cancers, including: Breast, lung, prostate, colorectal, pancreatic, liver, skin (melanoma), bladder, kidney, thyroid, brain, cervical, ovarian, uterine, esophageal, gastric, head and neck, bone, testicular, Hodgkin lymphoma, non-Hodgkin lymphoma, leukemia, multiple myeloma, oral, eye, gallbladder, small intestine, anal, vulvar, penile, mesothelioma, and rare pediatric cancers.

We welcome submissions that highlight clinical innovation, experimental studies, or translational research that bridge laboratory findings with clinical practice.

Journal of Oncology & Targeted Therapies: Open Access strongly supports the Open Access initiative, ensuring that all content—abstracts and full-text articles in HTML, PDF, and XML formats—is freely available online immediately upon publication. This model enables unrestricted access to the latest scientific advancements for researchers, clinicians, educators, and policymakers around the globe.